Wegovy vs Ozempic vs Mounjaro: Which Results in the Best Weight Loss?

Patrick Campbell • 15 August 2025

Weight-loss injections have become a hot topic. Three in particular—Wegovy (semaglutide), Ozempic (semaglutide for diabetes), and Mounjaro (tirzepatide)—are often discussed. Here’s how they compare, based on evidence and FAQs.

Wegovy, Ozempic and Mounjaro: Which Weight Loss Injection Is Right for You?


In recent years, injectable medications for weight loss have gained enormous popularity. From celebrity endorsements to NHS pilot schemes, medications like Wegovy, Ozempic and Mounjaro have become common talking points in the UK. But with so many names—and even more hype—it’s easy to feel overwhelmed when trying to understand what they are, how they work, and whether they’re right for you.


This blog offers a clear, practical comparison of the three main injectable medications used for weight loss: Wegovy (semaglutide), Ozempic (semaglutide), and Mounjaro (tirzepatide). We'll explore how they work, how much weight people typically lose on them, common side effects, and frequently asked questions, so you can make an informed decision.


How They Work


All three medications help regulate appetite by mimicking hormones that affect blood sugar and feelings of fullness. Wegovy and Ozempic both contain semaglutide, which mimics the GLP-1 hormone. Mounjaro contains tirzepatide, which mimics both GLP-1 and another hormone called GIP, offering a dual-action approach.


These hormones slow digestion, reduce appetite, and help regulate insulin levels, making you feel fuller for longer and less likely to overeat. Mounjaro’s additional mechanism is believed to enhance its effectiveness compared to semaglutide-based treatments.


How Much Weight Can You Lose?


Clinical trials have shown significant differences in the level of weight loss achieved across the three medications.


Wegovy users lost, on average, about 14.9% of their body weight over 68 weeks in clinical trials. In comparison, Mounjaro users saw an average weight loss of up to 22% over 72 weeks, making it the most effective weight loss injection on the market today. Ozempic, which was originally developed for managing type 2 diabetes rather than weight loss, generally results in weight loss of around 10–15% of body weight, depending on the dose and the individual's circumstances.


It’s important to note that while these figures are averages from controlled clinical settings, real-world results vary. Weight loss may be lower for people who don’t make accompanying lifestyle changes, or who experience difficulties with side effects or adherence.


Side Effects to Be Aware Of


The most commonly reported side effects across all three medications include nausea, vomiting, constipation, diarrhoea, and stomach discomfort. These symptoms tend to occur most frequently when starting treatment or increasing the dose, and often settle over time.


In rare cases, more serious issues such as pancreatitis or gallbladder problems have been reported, which is why all of these medications should only be used under medical supervision. There have also been anecdotal reports of hair thinning, fatigue, and muscle loss, especially if weight is lost too rapidly.


An important point for many patients to consider is that weight is often regained when the medication is stopped—especially if lifestyle changes aren't maintained during and after treatment. Support around nutrition, mindset and movement is key to long-term success.


Mounjaro vs Wegovy vs Ozempic: A Quick Comparison

Feature Wegovy Ozempic Mounjaro
Active Ingredient Semaglutide Semaglutide Tirzepatide
Original Use Weight loss Type 2 diabetes Type 2 diabetes & weight loss
Avg. Weight Loss ~15% ~10–15% ~20–22%
Hormone Target GLP-1 GLP-1 GLP-1 & GIP
Frequency Weekly injection Weekly injection Weekly injection
Side Effects GI symptoms common GI symptoms common Slightly higher rate of GI issues but stronger results
Available in UK? Yes (NHS and private) Yes (NHS and private) Private only (as of 2025)

Common Questions About Weight Loss Injections

Are these medications safe?
Yes, when prescribed and monitored by a qualified medical professional. However, they're not suitable for everyone, especially those with a history of certain cancers or pancreatitis.

Can I take them long-term?
Weight loss is maintained while on the medication, but many patients regain weight after stopping. Long-term treatment may be necessary, depending on your goals and health.

Will they work without diet and exercise?
You may see some results with medication alone, but combining it with a healthy lifestyle leads to significantly better and more sustainable outcomes.

Can I switch between them?
In some cases, yes—but this should be done under medical advice. Some patients begin with Ozempic and transition to Wegovy or Mounjaro depending on results and tolerance.

Which one is right for me?
That depends on your weight loss goals, medical history, budget, and how you respond to the treatment. A healthcare provider can help guide the decision.



Final Thoughts

All three medications—Wegovy, Ozempic and Mounjaro—offer safe and effective options to support weight loss when used appropriately. Mounjaro tends to deliver the most significant results, while Wegovy offers a strong, established option with wide availability. Ozempic may still be suitable, especially for patients with diabetes, though it’s slightly less potent for weight loss compared to the others.

Whichever route you choose, remember that these treatments are most successful when used as part of a wider plan that includes mindset support, physical activity, and healthy nutrition. Working with an experienced clinical team can help you stay on track and ensure your health and wellbeing are prioritised every step of the way.


References

  • JAMA Internal Medicine: Comparison of Tirzepatide vs Semaglutide for Weight Loss
  • Wired: Why GLP-1 Medications Don't Always Work for Everyone
  • NHS: Weight loss treatments and medication eligibility
  • Openhouse Clinic: SURMOUNT-5 trial outcomes for tirzepatide
  • Health.com: GLP-1s and how they impact weight
  • Which? Magazine: Weight loss injections explained
  • WebMD: Understanding Mounjaro and Semaglutide differences
  • The Sun: Regain of weight after stopping GLP-1 medications
by Patrick Campbell 13 August 2025
There’s no easy way to put it — the sudden closure of Private Midwives has left a real void, both professionally and personally, for many highly experienced tongue tie practitioners. It’s disrupted livelihoods, interrupted the continuity of care for families, and forced many to face a wave of uncertainty.
Kube Medical  August 2025
by Patrick Campbell 9 August 2025
All the latest news from the Kube Medical and Baby Acorn team in August 2025
Kube Medical | Physiotherapy on Insurance
by Patrick Campbell 15 July 2025
Imagine this: you’ve tweaked your back lifting something awkward, your GP suggests physio — and you remember you’ve got private health insurance with Bupa or AXA. But then you check online and… your local provider in Faringdon isn’t showing up. Frustrating, right? The good news is: Kube Medical in Faringdon is registered and ready to accept Bupa and AXA patients — even if we’re not currently showing on Bupa’s location finder.  Let’s clear up the confusion and walk you through what to do next.
by Patrick Campbell 30 June 2025
Faringdon, Oxfordshire – 30th June 2025 – Kube Medical, a leading provider of integrated musculoskeletal care, is proud to announce the opening of its second clinic at Wicklesham Lodge Farm in Faringdon on 1st July 2025. Known for its collaborative and patient-first approach, Kube Medical brings its award-winning services to Faringdon and the surrounding rural communities.
Kube Medical | Clinical Integrity
by Patrick Campbell 14 June 2025
Like many businesses in healthcare, we sometimes receive feedback that is difficult to read — not because it challenges us, but because it doesn’t reflect the care and intention with which our team works every day. Recently, a negative review was shared online that has been mentioned by both current and prospective patients. While we always value constructive feedback and use it to review our processes, I wanted to take a moment — from my perspective as a non-clinical Director — to clarify how we work, and the values that guide our decisions when it comes to patient care.
Kube Medical | June 2025
by Patrick Campbell 1 June 2025
Hello June! We’ve got plenty of exciting updates this month—from new events and workshops to a big announcement about our next chapter. Here’s everything you need to know from the team at Kube Medical.
Kube Medical | Carpal Tunnel or TOS
by Erika Anderson 24 May 2025
Is It Carpal Tunnel or Thoracic Outlet Syndrome? Here's How to Tell the Difference – and Why It Matters
Kube Medical | Newsletter May 2025
by Patrick Campbell 7 May 2025
Hello May! As the days grow longer and the sun starts to show its face, we’ve got some exciting updates, new faces, and a few dates for your diary. Here's what's happening at Kube Medical this month.
by Pearl Doiphode 3 May 2025
As a Physiotherapist with over six years of experience working with athletes, I've encountered a pattern that’s all too familiar — the dedicated, driven sports person who finds themselves stuck in limbo after an injury. One particular case stands out, and it’s a scenario I see frequently, especially with individuals recovering from sports injuries in Swindon.
by Erika Anderson 24 April 2025
Every so often, I come across someone who’s been told, or believes, they have cervical kyphosis. It’s a term that sounds serious and often sparks fear, confusion, or a sudden identity shift: “I have a curved neck; I must be broken.” Today, I saw just that—someone on social media seeking help after self-diagnosing with cervical kyphosis.